Table 2.
Therapy options for Alzheimer’s disease. IR = immediate release; ODT = orally disintegrating; ER = extended release; NMDA = N-methyl-D-aspartate.
| Drug | Brand Name | Approved for | Year | Dosageform |
|---|---|---|---|---|
| Cholinesterase inhibitor | ||||
| Donepezil | Aricept® | All stages | 1996 | IR tablet ODT |
| Galantamine | Razadyne® | Mild to Moderate | 2001 | IR tabletsER tablets |
| Rivastigmine | Exelon® | All stages | 2000 | IR capsulesOralsolution |
| NMDA-receptor antagonist | ||||
| Memantine | Namenda® | Moderate to severe | 2003 | IR tablets |
| Cholinesterase inhibitor/NMDA-receptor antagonist | ||||
| Donepezil and Memantine | Namzaric® | Moderate to severe | 2014 | / |